Engineered immune effector cells for cancer immunotherapy that are resistant to fratricide by virtue of having genetically modified surface antigens
US-12576148-B2 · Mar 17, 2026 · US
Mitenyi Biotec B V & Co Kg holds 1 patent in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 1 |
| Recent patents | 1 |
| First publication | Mar 17, 2026 |
| Latest publication | Mar 17, 2026 |
Year-over-year patent counts for this assignee.
Not enough yearly data to assess filing trend yet.
| Year | Patents |
|---|---|
| 2026 | 1 |
| Year | Patents |
|---|---|
| 2026 | 1 |
Latest publications where this party is an assignee.
Representative or frequently cited publications from precomputed assignee stats.
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 1 |